34 related articles for article (PubMed ID: 2911656)
1. Diagnostic performance of
Plodeck V; Platzek I; Streitzig J; Nebelung H; Blum S; Kühn JP; Hoffmann RT; Laniado M; Michler E; Hoberück S; Zöphel K; Kotzerke J; Fritzmann J; Weitz J; Radosa CG
Abdom Radiol (NY); 2021 Nov; 46(11):5086-5094. PubMed ID: 34402948
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.
Shao H; Ma X; Gao Y; Wang J; Wu J; Wang B; Li J; Tian J
Medicine (Baltimore); 2018 Nov; 97(48):e12900. PubMed ID: 30508883
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.
Plodeck V; Rahbari NN; Weitz J; Radosa CG; Laniado M; Hoffmann RT; Zöphel K; Beuthien-Baumann B; Kotzerke J; van den Hoff J; Platzek I
Eur Radiol; 2019 Jan; 29(1):422-428. PubMed ID: 29980927
[TBL] [Abstract][Full Text] [Related]
4. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer.
Lambregts DM; Cappendijk VC; Maas M; Beets GL; Beets-Tan RG
Eur Radiol; 2011 Jun; 21(6):1250-8. PubMed ID: 21240647
[TBL] [Abstract][Full Text] [Related]
5. The importance of rectal cancer MRI protocols on interpretation accuracy.
Suzuki C; Torkzad MR; Tanaka S; Palmer G; Lindholm J; Holm T; Blomqvist L
World J Surg Oncol; 2008 Aug; 6():89. PubMed ID: 18715510
[TBL] [Abstract][Full Text] [Related]
6. The role of FDG-PET/CT in the detection of recurrent colorectal cancer.
Votrubova J; Belohlavek O; Jaruskova M; Oliverius M; Lohynska R; Trskova K; Sedlackova E; Lipska L; Stahalova V
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):779-84. PubMed ID: 16565845
[TBL] [Abstract][Full Text] [Related]
7. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity.
Ito K; Kato T; Ohta T; Tadokoro M; Yamada T; Ikeda M; Nishino M; Ishigaki T; Gambhir S
Eur J Nucl Med; 1996 Oct; 23(10):1372-7. PubMed ID: 8781143
[TBL] [Abstract][Full Text] [Related]
9. Pelvic resection of recurrent rectal cancer.
Wanebo HJ; Koness RJ; Vezeridis MP; Cohen SI; Wrobleski DE
Ann Surg; 1994 Oct; 220(4):586-95; discussion 595-7. PubMed ID: 7524455
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis?
Balzarini L; Ceglia E; D'Ippolito G; Petrillo R; Tess JD; Musumeci R
Gastrointest Radiol; 1990; 15(4):338-42. PubMed ID: 2210210
[TBL] [Abstract][Full Text] [Related]
11. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103.
Neal CE; Swan TL; Baker MR; Ellis RL; Katterhagen JG
Gastrointest Radiol; 1991; 16(3):251-5. PubMed ID: 1879645
[TBL] [Abstract][Full Text] [Related]
13. Locally recurrent rectal cancer: surgical strategy.
de Azevedo JP; Dozois RR; Gunderson LL
World J Surg; 1992; 16(3):490-4. PubMed ID: 1589986
[TBL] [Abstract][Full Text] [Related]
14. Superimposition of computed tomography and single photon emission tomography immunoscintigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrence.
Liehn JC; Loboguerrero A; Pérault C; Demange L
Eur J Nucl Med; 1992; 19(3):186-94. PubMed ID: 1572383
[TBL] [Abstract][Full Text] [Related]
15. Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings.
de Lange EE; Fechner RE; Wanebo HJ
Radiology; 1989 Feb; 170(2):323-8. PubMed ID: 2911656
[TBL] [Abstract][Full Text] [Related]
16. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging in suspected rectal cancer: determining tumor localization, stage, and sphincter-saving resectability at 3-Tesla-sustained high resolution.
Winter L; Bruhn H; Langrehr J; Neuhaus P; Felix R; Hänninen LE
Acta Radiol; 2007 May; 48(4):379-87. PubMed ID: 17453515
[TBL] [Abstract][Full Text] [Related]
18. [Differentiation of recurrence rectal cancer and benign pelvic lesions after curative rectal operation with 3.0 T magnetic resonance].
Wang LL; Duan Q; Xue YQ; Huang XM; Wang CS; Sun B
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):859-63. PubMed ID: 22116720
[TBL] [Abstract][Full Text] [Related]
19. Restaging of Rectal Cancer with MR Imaging after Concurrent Chemotherapy and Radiation Therapy.
Kim DJ; Kim JH; Lim JS; Yu JS; Chung JJ; Kim MJ; Kim KW
Radiographics; 2010 Mar; 30(2):503-16. PubMed ID: 20228331
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
